<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02292953</url>
  </required_header>
  <id_info>
    <org_study_id>A13952014</org_study_id>
    <nct_id>NCT02292953</nct_id>
  </id_info>
  <brief_title>Variation in Serum Prolactin Levels During IntraCytoplasmic Sperm Injection</brief_title>
  <official_title>Variation in Serum Prolactin Levels in Response to Ovum Pickup for Patients Undergoing ICSI &amp; it's Effect on Pregnancy Rate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kasr El Aini Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kasr El Aini Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether or not stressful conditions such as ovum&#xD;
      pick and awaiting Embryo Transfer is associated with significant increase in serum Prolactin&#xD;
      (PRL) concentration in some normo-prolactinemic patients undergoing intracytoplasmatic sperm&#xD;
      injection (ICSI) &amp; possible effect on implantation &amp; pregnancy rate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methodology in details:&#xD;
&#xD;
      After applying inclusion and exclusion criteria to infertile patients scheduled for start of&#xD;
      ICSI cycle at kasr alainy assisted reproduction unit, and taking the patient's informed&#xD;
      consent for all blood samples that will be drawn from her.&#xD;
&#xD;
      The baseline serum prolactin level is recorded and the first blood sample is scheduled to be&#xD;
      taken in operating room just before induction of anesthesia for ovum pickup. A Second blood&#xD;
      sample will be taken two hours after aspiration of the last follicle in recovery room&#xD;
      post-operatively.&#xD;
&#xD;
      A third final blood sample will be taken before Embryo transfer .The blood samples will be&#xD;
      sent immediately to central laboratory in Kasr Alainy Cairo University Hospital after being&#xD;
      obtained on every occasion, and Serum prolactin will be analyzed by immunoassay in each time.&#xD;
&#xD;
      Descriptive data such as age, type of infertility &amp; cause will be recorded. Also result of&#xD;
      every serum prolactin level will be recorded as well as type of protocol used for ovulation&#xD;
      induction, number of oocytes retrieved at ovum pick up, embryo grading and day of transfer.&#xD;
&#xD;
      Serum beta human chorionic gonadotropin (B-hCG) will be drawn from the patient 2 weeks after&#xD;
      the date of embryo transfer to determine pregnancy and recorded.&#xD;
&#xD;
      Statistical analysis will be done for the laboratory results, All statistical calculations&#xD;
      were performed using the computer program SPSS (Statistical Package for the Social Science;&#xD;
      SPSS Inc.) version 15 for Microsoft Windows&#xD;
&#xD;
      .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">May 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Difference in Serum prolactin Levels (ng/mL) between ovum pickup &amp; Embryo transfer</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>o Correlate serum prolactin levels (ng/mL) with Pregnancy rate.</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlate serum prolactin levels (ng/mL) with number &amp; quality of embryos</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Infertility</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serum Prolactin levels</intervention_name>
    <description>blood samples will be drawn from patients undergoing ICSI to analyse serum prolactin levels</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ninety normo-prolactinemic patients attending the Assisted reproduction unit in the&#xD;
        Obstetrics and Gynecology Department-Faculty of Medicine -Cairo University, Scheduled for&#xD;
        ICSI treatment cycle .Each participant will be subjected to infertility work up&#xD;
        investigation in the form of semen analysis, hormonal profile (FSH, LH, TSH and prolactin).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: adult female &gt;20 years old.&#xD;
&#xD;
          -  Complaining of infertility 1ry or 2ry &amp; scheduled for ICSI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hyperprolactinemia patients.&#xD;
&#xD;
          -  Severe Male factor infertility&#xD;
&#xD;
          -  Frozen embryo transfer cycles&#xD;
&#xD;
          -  Uterine Anomalies.&#xD;
&#xD;
          -  Repeated implantation failure in ICSI.&#xD;
&#xD;
          -  Any contraindications for Pregnancy as(serious uncontrolled medical diseases such as&#xD;
             Diabetes, heart disease, hypertension), mental illnesses, ovarian tumors,cancer of any&#xD;
             location and Acute inflammatory disease).&#xD;
&#xD;
          -  On medication that is known to alter prolactin levels e.g antipsychotics, Atypical&#xD;
             agents and risperidone&#xD;
&#xD;
          -  Thyroid dysfunction.&#xD;
&#xD;
          -  Medical disorders affecting serum prolactin eg acromegaly ,chronic renal failure and&#xD;
             hypothyroidism.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ahmed M Kamel, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Lecturer Of obstetrics &amp; Gynecology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ahmed M Kamel, MD</last_name>
    <phone>01120022332</phone>
    <email>dr.ahmed.m.kamel@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>11562</name>
      <address>
        <city>Garden City</city>
        <state>Cairo</state>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed M KameL, M.D</last_name>
      <phone>01120022332</phone>
      <email>dr.ahmed.m.kamel@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Boyers SP, Lavy G, Russell JB, Polan ML, DeCherney AH. Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer. J In Vitro Fert Embryo Transf. 1987 Oct;4(5):269-72.</citation>
    <PMID>2961832</PMID>
  </reference>
  <verification_date>November 2014</verification_date>
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 18, 2014</study_first_posted>
  <last_update_submitted>November 17, 2014</last_update_submitted>
  <last_update_submitted_qc>November 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kasr El Aini Hospital</investigator_affiliation>
    <investigator_full_name>Ahmed M.Kamel</investigator_full_name>
    <investigator_title>Lecturer of Obstetric &amp; Gynecology</investigator_title>
  </responsible_party>
  <keyword>ICSI</keyword>
  <keyword>Ovum Pickup</keyword>
  <keyword>Embryo Transfer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>May 4, 2015</submitted>
    <returned>May 19, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

